Among these variables, the only significant differences between groups were a higher educational level for controls (though this association was only nominally significant) and the use of two disease treatment drugs, cholinesterase inhibitor and/or memantine, in a subset of AD participants (Table 1). Here, BCHE is linked to Alzheimer disease.